ATE138100T1 - Fusionen von aids-verwandten polypeptiden - Google Patents
Fusionen von aids-verwandten polypeptidenInfo
- Publication number
- ATE138100T1 ATE138100T1 AT85309454T AT85309454T ATE138100T1 AT E138100 T1 ATE138100 T1 AT E138100T1 AT 85309454 T AT85309454 T AT 85309454T AT 85309454 T AT85309454 T AT 85309454T AT E138100 T1 ATE138100 T1 AT E138100T1
- Authority
- AT
- Austria
- Prior art keywords
- aids
- associated retrovirus
- reverse transcriptase
- diagnostic product
- vaccine
- Prior art date
Links
- 208000030507 AIDS Diseases 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 241000714195 Aids-associated retrovirus Species 0.000 abstract 3
- 102100034343 Integrase Human genes 0.000 abstract 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 abstract 2
- 239000012502 diagnostic product Substances 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000001236 prokaryotic cell Anatomy 0.000 abstract 1
- 230000001177 retroviral effect Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68527284A | 1984-12-24 | 1984-12-24 | |
US80506985A | 1985-12-04 | 1985-12-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE138100T1 true ATE138100T1 (de) | 1996-06-15 |
Family
ID=27103546
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT85309454T ATE138100T1 (de) | 1984-12-24 | 1985-12-23 | Fusionen von aids-verwandten polypeptiden |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0187041B1 (de) |
AT (1) | ATE138100T1 (de) |
AU (1) | AU600658B2 (de) |
CA (1) | CA1341476C (de) |
DE (1) | DE3588134T2 (de) |
MY (1) | MY102030A (de) |
Families Citing this family (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4716102A (en) * | 1984-08-15 | 1987-12-29 | Regents Of The University Of California | Purified AIDS-associated virus ARV-2 |
US9328391B1 (en) | 1984-08-22 | 2016-05-03 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Cloning and expression of HIV-1 DNA |
DE122005000039I1 (de) | 1984-10-18 | 2006-02-23 | Pasteur Institut | DNS-Fragmente des GAG-Gens von LAV |
US7273695B1 (en) | 1984-10-31 | 2007-09-25 | Novartis Vaccines And Diagnostics, Inc. | HIV immunoassays using synthetic envelope polypeptides |
US7285271B1 (en) | 1984-10-31 | 2007-10-23 | Novartis Vaccines And Diagnostics, Inc. | Antigenic composition comprising an HIV gag or env polypeptide |
CA1341423C (en) | 1984-10-31 | 2003-03-04 | Paul A. Luciw | Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome |
US5176995A (en) * | 1985-03-28 | 1993-01-05 | Hoffmann-La Roche Inc. | Detection of viruses by amplification and hybridization |
US5008182A (en) * | 1986-01-10 | 1991-04-16 | Cetus Corporation | Detection of AIDS associated virus by polymerase chain reaction |
IE64785B1 (en) * | 1985-04-08 | 1995-09-06 | Genetic Systems Corp | Expression of immunologically reactive viral proteins |
DE3650011T2 (de) * | 1985-04-08 | 1994-11-17 | Genetic Systems Corp | EXPRESSION UND DIAGNOSE MIT gag-KODIERTEN PEPTIDEN, DIE MIT ANTIKÖRPERN GEGEN LAV IMMUNOLOGISCH REAKTIV SIND. |
JP2869063B2 (ja) * | 1985-04-08 | 1999-03-10 | ジエネテイツク システムズ コ−ポレイシヨン | LAVに対する抗体と免疫的に反応性であるgagによりコードされたペプチドの発現及び使用 |
DK171119B1 (da) * | 1985-04-19 | 1996-06-17 | Hoffmann La Roche | AIDS-viruskappeprotein, ekspressionsvektor bærende viruskappeproteinet, transformanter transformeret med ekspressionsvektoren, fremgangsmåde til fremstilling af viruskappeproteinet, fremgangsmåde til detektion af AIDS-antistoffer, fremgangsmåde til bestemmelse af AIDS-virus, vaccine mod AIDS, antistoffer mod viruskappeproteinet samt anvendelse af dette til fremstilling af en vaccine og til testnin |
US5773210A (en) * | 1985-04-19 | 1998-06-30 | The United States Of America As Represented By The Department Of Health And Human Services | Acquired immune deficiency syndrome (AIDS) viral envelope protein and method of testing for AIDS |
FR2593519B1 (fr) * | 1985-09-25 | 1994-01-07 | Oncogen | Vaccin contre le syndrome immunodeficitaire acquis et intermediaires pour la preparation de ce vaccin |
GR862412B (en) * | 1985-09-25 | 1987-01-23 | Oncogen | Vaccines and immuinoassays for acquired immune deficiency syndrome |
GB8525615D0 (en) * | 1985-10-17 | 1985-11-20 | Hoffmann La Roche | Polypeptides |
WO1987002775A1 (en) * | 1985-10-24 | 1987-05-07 | Southwest Foundation For Biomedical Research | Synthetic peptides and use for diagnosis and vaccination for aids and arc |
US5068174A (en) * | 1985-11-07 | 1991-11-26 | President And Fellows Of Harvard College | T-cell lymphotrophic virus protein and assay |
JP2837669B2 (ja) * | 1985-11-07 | 1998-12-16 | プレジデント アンド フエロウズ オブ ハ−バ−ド カレツジ | T−細胞リンパ趨行性ウイルス蛋白及びその分析 |
DE3674555D1 (de) * | 1985-12-20 | 1990-10-31 | Abbott Lab | Immuntest fuer antikoerper gegen htlv-iii. |
EP0230222A1 (de) * | 1986-01-06 | 1987-07-29 | F. Hoffmann-La Roche Ag | Expression des HTLV-III Gag-Gens |
US5364933A (en) | 1986-03-03 | 1994-11-15 | Institut Pasteur | Methods of immunopurification of antigens of human immunodeficiency virus type 2 (HIV-2) |
US4839288A (en) * | 1986-01-22 | 1989-06-13 | Institut Pasteur | Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes |
US6514691B1 (en) | 1986-01-22 | 2003-02-04 | Institut Pasteur | Peptides of human immunodeficiency virus type 2 (HIV-2), antibodies against peptides of HIV-2, and methods and kits for detecting HIV-2 |
US4753873A (en) * | 1986-02-03 | 1988-06-28 | Cambridge Bioscience Corporation | Peptides for the diagnosis of HTLV-III antibodies, their preparation and use |
US4734362A (en) * | 1986-02-03 | 1988-03-29 | Cambridge Bioscience Corporation | Process for purifying recombinant proteins, and products thereof |
FR2625100A2 (fr) * | 1986-03-13 | 1989-06-30 | Lurhuma Zirimwabagabo | Utilisation d'antigenes pour la preparation de vaccins, proteine rendue immunogene et composition pharmaceutique la comportant |
US4925784A (en) * | 1986-04-04 | 1990-05-15 | Hoffmann-La Roche Inc. | Expression and purification of an HTLV-III gag/env gene protein |
US4983387A (en) * | 1986-05-19 | 1991-01-08 | Viral Technologies Inc. | HIV related peptides, immunogenic antigens, and use therefor as subunit vaccine for AIDS virus |
US5604114A (en) * | 1986-05-20 | 1997-02-18 | Dana-Farber Cancer Institute | Cis-acting repression sequences, cis-acting antirepression sequences, vectors, methods of preparation and use |
US4943627A (en) * | 1986-06-12 | 1990-07-24 | Biogen, Inc. | Peptides involved in the pathogenesis of HIV infection |
US5017688A (en) * | 1986-06-12 | 1991-05-21 | Biogen, Inc. | Peptides involved in the pathogenesis of HIV infection |
EP0255190A3 (de) * | 1986-08-01 | 1990-08-29 | Repligen Corporation | Rekombinante Polypeptide und ihre Verwendungen sowie Test für den AIDS-Virus |
US5079351A (en) * | 1986-11-26 | 1992-01-07 | Cetus Corporation | Oligonucleotides and kits for detection of htlvi and htlvii viruses by hybridization |
ES2104556T3 (es) * | 1987-01-16 | 1997-10-16 | Pasteur Institut | Peptidos que tienen propiedades inmunologicas de hiv-2. |
FR2610632B1 (fr) * | 1987-02-11 | 1990-12-21 | Pasteur Institut | Peptides caracteristiques des retrovirus d'immunodeficience humaine (virus hiv) leurs applications au diagnostic des infections dues a certains de ces virus et, le cas echeant, a la vaccination contre le sida |
EP0279688B1 (de) * | 1987-02-20 | 1997-04-16 | Genentech, Inc. | Verfahren und Zubereitungen für die Verwendung von HIV-env-Polypeptiden und Antikörpern |
NO881239L (no) * | 1987-03-23 | 1988-09-26 | Ortho Pharma Corp | Analyse for detektering av hepatitt-antigener og aids-antistoffer. |
AU620330B2 (en) * | 1987-05-29 | 1992-02-20 | Smithkline Beckman Corporation | Immunodiagnostic assays using chimeric antigens |
EP0293181B1 (de) * | 1987-05-29 | 1995-08-16 | Dana Farber Cancer Institute | Cis-Wirkung-Repressionen-Sequenzen, Cis-Wirkung-Antirepressionen-Sequenzen, Vektoren, Verfahren zur Vorbereitung und Anwendung |
EP0685236A1 (de) * | 1987-06-10 | 1995-12-06 | The Immune Response Corporation, Inc. | Verhütung und Behandlung einer Retrovirenkrankheit |
US5256767A (en) * | 1987-06-10 | 1993-10-26 | The Immune Response Corporation | Retroviral antigens |
DE3727137A1 (de) * | 1987-08-14 | 1989-02-23 | Behringwerke Ag | Herstellung von antigenen des human immunodeficiency virus typ 1 sowie deren verwendung als diagnostisches mittel und therapeutikum |
IL87391A0 (en) * | 1987-08-27 | 1989-01-31 | Repligen Corp | Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them |
NZ226026A (en) * | 1987-09-04 | 1991-03-26 | Wellcome Found | Immunoassay for an antibody using recombinant antigens expressed in two different genera |
US7442525B1 (en) | 1987-12-24 | 2008-10-28 | Novartis Vaccines And Diagnostics, Inc. | Method for expressing HIV polypeptides |
EP0349354A1 (de) * | 1988-04-01 | 1990-01-03 | Institut Pasteur | Peptide PF10 bis PF19 von einem Retrovirus HIV, Verfahren zur Synthese dieser Peptide und ihre Verwendung, insbesondere zur Diagnose |
FR2629459B1 (fr) * | 1988-04-01 | 1990-12-21 | Pasteur Institut | Peptides pf11 a pf19 d'un retrovirus hiv - procede de synthese de ces peptides - leur utilisation notamment pour le diagnostic |
FR2629460B1 (fr) * | 1988-04-01 | 1990-12-21 | Pasteur Institut | Peptides pf16 d'un retrovirus hiv - procede de synthese de ces peptides - leur utilisation pour le diagnostic |
US5204259A (en) * | 1988-05-06 | 1993-04-20 | Pharmacia Genetic Engineering, Inc. | Methods and systems for producing HIV antigens |
ATE110112T1 (de) * | 1988-05-06 | 1994-09-15 | Ferropas Ag | Verfahren und systeme zur herstellung von hiv- antigenen. |
EP0434713B1 (de) * | 1988-09-13 | 1994-10-12 | Chiron Corporation | Mutanten des hiv-1 Hüllproteins mit fehlenden hypervariabelen domänen. |
EP0361749B1 (de) * | 1988-09-27 | 1995-02-08 | Dana Farber Cancer Institute | Vektor, der ein replikationskompetentes HIV-I-Provirus und ein heterologes Gen enthält |
CA2003383A1 (en) * | 1988-11-23 | 1990-05-23 | Sushil G. Devare | Synthetic dna derived recombinant hiv antigens |
ATE125157T1 (de) * | 1990-04-03 | 1995-08-15 | Genentech Inc | Methoden und zusammensetzungen zur impfung gegen hiv. |
US7041293B1 (en) | 1990-04-03 | 2006-05-09 | Genentech, Inc. | HIV env antibodies |
US6316182B1 (en) * | 1992-01-15 | 2001-11-13 | Nen Life Science Products, Inc. | Detection of reverse transcriptase by DNA hybridization assay |
AU700371B2 (en) | 1993-06-07 | 1999-01-07 | Genentech Inc. | Hiv envelope polypeptides |
US6479055B1 (en) | 1993-06-07 | 2002-11-12 | Trimeris, Inc. | Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission |
DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
US6585979B1 (en) | 1996-07-08 | 2003-07-01 | Genentech, Inc. | HIV envelope polypeptides and immunogenic composition |
ZA975889B (en) * | 1996-07-08 | 1998-02-23 | Genentech Inc | HIV envelope polypeptides and vaccine. |
DE19723463A1 (de) * | 1997-06-04 | 1998-12-10 | Dade Behring Marburg Gmbh | Immunchemische Bestimmung von multivalenten Analyten |
EP1141313A2 (de) | 1998-12-31 | 2001-10-10 | Chiron Corporation | Verbesserte exprimierung von hiv polypeptiden und herstellung von virusähnliche partikeln |
WO2000039303A2 (en) | 1998-12-31 | 2000-07-06 | Chiron Corporation | Modified hiv env polypeptides |
AU2487300A (en) | 1998-12-31 | 2000-07-31 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
US7935805B1 (en) | 1998-12-31 | 2011-05-03 | Novartis Vaccines & Diagnostics, Inc | Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
AU2002320314A1 (en) | 2001-07-05 | 2003-01-21 | Chiron, Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
WO2003020876A2 (en) | 2001-08-31 | 2003-03-13 | Chiron Corporation | Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
US20030170614A1 (en) | 2001-08-31 | 2003-09-11 | Megede Jan Zur | Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
CN106434833A (zh) | 2004-05-23 | 2017-02-22 | 杰勒德·M·豪斯 | Theramutein调节剂 |
US8431110B2 (en) | 2005-05-23 | 2013-04-30 | Hmi Medical Innovations, Llc. | Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8324800D0 (en) * | 1983-09-15 | 1983-10-19 | Pasteur Institut | Antigens |
IE58321B1 (en) * | 1984-04-23 | 1993-09-08 | Us Health | Isolation of proteins of HTLV-III, serological detection of antibodies to HTLV-III in sera of patients with aids and pre-aids conditions, and detection of HTLV-III infection bi/immuno-assays using HTLV-III infection by immuno-assays using HTLV-III and its proteins |
IL76082A (en) * | 1984-08-22 | 1991-07-18 | Us Health | Molecular clones of the genome of htlv-iii and a process for the preparation thereof |
-
1985
- 1985-12-23 EP EP85309454A patent/EP0187041B1/de not_active Revoked
- 1985-12-23 AT AT85309454T patent/ATE138100T1/de not_active IP Right Cessation
- 1985-12-23 AU AU51705/85A patent/AU600658B2/en not_active Expired
- 1985-12-23 DE DE3588134T patent/DE3588134T2/de not_active Expired - Lifetime
- 1985-12-24 CA CA000498600A patent/CA1341476C/en not_active Expired - Lifetime
-
1987
- 1987-09-24 MY MYPI87001924A patent/MY102030A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA1341476C (en) | 2005-03-15 |
MY102030A (en) | 1992-02-29 |
DE3588134D1 (de) | 1997-01-23 |
DE3588134T2 (de) | 1997-03-20 |
AU600658B2 (en) | 1990-08-23 |
AU5170585A (en) | 1986-10-16 |
EP0187041A1 (de) | 1986-07-09 |
EP0187041B1 (de) | 1996-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE138100T1 (de) | Fusionen von aids-verwandten polypeptiden | |
DK84194A (da) | Rekombinant hepatitis B-virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenetiske polypeptider, DNA-sekvenser kodende herfor, fremgangsmåder til påvisning af hepatitis B-virus antistoffer i blodserum, fremgangsmåder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider, midler til påvisn | |
DE3588252D1 (de) | Rekombinante Proteine von mit Lymphadenopathiesyndrom und/oder erworbenem Immunschwächesyndrom assoziierten Viren | |
DE69232871T2 (de) | Polypeptide des hepatitis c-virus (hiv) | |
ATE98992T1 (de) | Klonierung und expression von htlv-iii dns. | |
DK626486D0 (da) | Syntetiske antigener til afslaering af aids-relateret sygdom | |
ES8700441A1 (es) | Metodo de diagnostico de enfermedades y perfeccionamientos en los sistemas de ensayo de sueros | |
DE69534569D1 (de) | Hiv-1- und hiv-2-peptide zur hemmung von mit membranfusionen in zusammenhang stehenden phänomenen, einschliesslich der übertragung von hiv | |
SE9102976L (sv) | Hybrid dna vektorer, encelliga organismer och bakterier till anvaendning foer produktion av hiv-proteiner och peptider | |
ATE172542T1 (de) | Vergrössertes western blot format und ein immunotestverfahren für die bestimmung von viralen antikörpern | |
DE3650019D1 (de) | Expression von Virusproteinen mit immunologischer Aktivität. | |
DK0554389T3 (da) | Molekylære kloner af HIV-1 og anvendelse deraf | |
ATE420183T1 (de) | Antigen-konstrukte, für den nachweis und die unterscheidung von antikörpern gegen hiv | |
ATE87487T1 (de) | Rekombinante hiv-2 polypeptide. | |
DE3850593D1 (de) | Synthetische Antigene zur Bestimmung der AIDS-bezogenen, von LAV-2 verursachten Krankheiten. | |
ATE72459T1 (de) | Herstellung von einschlussproteinfragmenten von menschlichem t-zellen-leukemia-(lymphotropischem)-retrovirus (htlv-1) in bakterien und verwendung fuer die seroloimologische pruefung von menschlicher lymphoid-malignitaet. | |
DE69028561D1 (de) | Immunoassay zum Nachweis von Antikörpern gegen HIV | |
EP0270114A3 (de) | ENV/GAG-Polypeptide | |
DE68917520T2 (de) | Verfahren und Systeme zur Herstellung von HIV-Antigenen. | |
Lenz et al. | Serologische AIDS-Diagnostik mit gentechnisch gewonnenen Polypeptiden des menschlichen Immundefizienz-Virus (HIV-1) | |
Hashinaka et al. | Preparations of recombinant HIV‐1 p66 antigen to improve the specificity of immune complex transfer enzyme immunoassay of antibody IgG to HIV‐1 reverse transcriptase | |
Neumuller | DNA polymerase activity assays: New techniques and applications in tumor and viral diseases, notably HIV infection. | |
ES2155436T3 (es) | Proteinas recombinantes con la reactividad inmunologica del antigeno e del virus de la hepatitis b (hbeag), procedimiento para su preparacion y su utilizacion en analisis inmunologicos y en vacunas. | |
NO881501L (no) | Rekombinante htlv-111-proteiner og anvendelser av disse. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EELA | Cancelled due to lapse of time |